is focused on novel biocompatible polymer implant therapies to treat chronic heart failure, mitral valve regurgitation and post-operative atrial fibrillation.
is focused on novel biocompatible polymer implant therapies to treat chronic heart failure, mitral valve regurgitation and post-operative atrial fibrillation.